Physician profile
Szymon L Wiernek
NPI 1063709400
$22,479.88
in general payments reported to CMS, 2019-2025
11 companies · $14K in 2025
The $14K reported for 2025 was more than what 91% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,678 · 2020: $332 · 2022: $688 · 2023: $2,753 · 2024: $3,121 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,500 · Travel and Lodging: $6,711 · Food and Beverage: $5,571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,500.00 |
| Travel and Lodging | $6,711.43 |
| Food and Beverage | $5,570.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,120.18 | 2022-2025 | General - Balloons, Avvigo Guidance System, Opticross |
| Edwards Lifesciences Corporation | $4,616.86 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Abbott Laboratories | $4,021.86 | 2019-2025 | Mitraclip, Triclip, Amplatzer Talisman |
| Philips North America LLC | $1,704.73 | 2024 | (Bs3) Intracardiac Und, (9525) Intracardiac Und |
| Medtronic, INC. | $576.77 | 2024-2025 | Corevalve Evolut R |
| Abiomed | $448.54 | 2019 | |
| Chiesi USA, INC. | $389.72 | 2019-2020 | |
| Medtronic Vascular, INC. | $271.83 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $140.54 | 2019 | |
| Terumo Medical Corporation | $114.53 | 2019-2020 | |
| Shockwave Medical, INC | $74.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Szymon Wiernek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.